Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC).
Abdulghani J, Gokare P, Gallant JN, Dicker D, Whitcomb T, Cooper T, Liao J, Derr J, Liu J, Goldenberg D, Finnberg NK, El-Deiry WS.
Abdulghani J, et al. Among authors: goldenberg d.
Clin Cancer Res. 2016 Dec 15;22(24):6192-6203. doi: 10.1158/1078-0432.CCR-15-2792. Epub 2016 Jun 15.
Clin Cancer Res. 2016.
PMID: 27307592
Free PMC article.